News Pharma Industry

With a tweak in strategy, Dr. Reddy’s bets big on India. What will it need to make it to the top 5?


While the US is its biggest market, India — among the few markets that are growing well and underserved — has become the company’s most important play. Not only is the India business likely to be stable and profitable, it can also fetch high returns. Currently ranked No. 10, can Dr. Reddy’s use these advantages to break into Indian pharma’s top league?

In June, Dr. Reddy’s Laboratories announced it aims to be among the top five companies in the Indian pharmaceutical market in the “foreseeable future”. India has become its most important market and it will continue to allocate more capital to grow its domestic business. This is a marked change, because for years, Dr. Reddy’s main area of focus has been the US market. It was among the first Indian companies to tap the opportunities in the US

  • SAVE

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

Source link

Leave a Comment